Plain-English translation of NCT07135752 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is looking for new ways to identify and measure early warning signs in people with radiologically isolated syndrome—brain changes detected on MRI before any symptoms appear—and in people with multiple sclerosis who don't yet show physical symptoms. Researchers want to find digital biomarkers (measurable signs in the body or brain) that can better predict who will develop MS and how quickly the disease might progress.
Multiple sclerosis can cause permanent disability if not treated early, but doctors currently have limited tools to predict who will develop the disease or how it will progress. By studying these new biomarkers in people at different stages, researchers hope to catch MS earlier and better understand the transition from early brain changes to active disease.
You likely qualify if…
You likely don't qualify if…
As a participant, you would undergo digital testing and evaluations designed to measure biomarkers—measurable signs that may indicate MS progression. This likely includes brain and spinal cord MRI scans and neurological examinations, with follow-up visits planned to track any changes over time. The study is still recruiting participants, so your specific schedule and visit frequency would be discussed with the research team at the Nice University Hospital.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
France